Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy

Targeted therapies of chronic myeloid leukemia (CML) using tyrosine kinase inhibitors (TKI) have profoundly changed the natural history of the disease with a major impact on survival. Molecular monitoring with BCR-ABL quantification shows that a status of undetectable molecular residual disease (UMR...

Descripción completa

Detalles Bibliográficos
Autores principales: Chomel, Jean-Claude, Turhan, Ali G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248215/
https://www.ncbi.nlm.nih.gov/pubmed/21946665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248215/
https://www.ncbi.nlm.nih.gov/pubmed/21946665

Ejemplares similares